Basis for Inclusion: Vantive US Healthcare LLC donated $2.5 million to the Trump White House Ballroom renovation on October 13, 2025, two days before a Trump donor appreciation dinner, while simultaneously lobbying on Medicare ESRD reimbursement and dialysis policy. Vantive is the only ballroom donor known to have disclosed its contribution in federal lobbying filings. This profile documents the factual relationship between political donations and government actions affecting the donor. Inclusion is based on Anchor D (Financial transactions creating conflicts of interest in public office).

Overview

Vantive is a kidney care company that was spun off from Baxter International Inc. and sold to the Carlyle Group for $3.8 billion. The sale closed on January 31, 2025, with Baxter receiving approximately $3.4 billion in net after-tax proceeds [DOCUMENTED: Baxter International press release and SEC filing, January 31, 2025]. Vantive provides renal replacement therapies, including hemodialysis, peritoneal dialysis, and related products and services for patients with end-stage renal disease (ESRD) and acute kidney injury (AKI).

As a newly independent company backed by one of the world’s largest private equity firms, Vantive moved quickly to establish a Washington presence. Within its first year of independence, the company spent $1.86 million on federal lobbying and donated $2.5 million to the White House Ballroom project — a total of $4.36 million in documented political and access spending [DOCUMENTED: Lobbying disclosures; Vantive semiannual contribution report, reported by Bloomberg Government, 2026].

Vantive’s business is heavily dependent on Medicare reimbursement. Medicare’s ESRD Prospective Payment System pays approximately $6.6 billion annually to roughly 7,700 dialysis facilities [DOCUMENTED: CMS Final Rule CMS-1805-F, November 1, 2024]. Any changes to Medicare dialysis reimbursement rates, coverage policies, or quality program requirements directly affect Vantive’s revenue.

Political Spending and Access

White House Ballroom Donation

Vantive US Healthcare LLC donated $2.5 million to the Trust for the National Mall for the White House Ballroom project on October 13, 2025 — two days before an October 15 Trump donor appreciation dinner at the White House [DOCUMENTED: Vantive semiannual contribution filing with Congress, reported by Bloomberg Government, 2026].

Vantive is the only ballroom donor known to have disclosed its contribution in its federal lobbying disclosure filings. The Citizens for Responsibility and Ethics in Washington (CREW) found that at least 23 reported ballroom contributors should have disclosed their donations as part of regular lobbying disclosures, but only Vantive did so [DOCUMENTED: CREW analysis, 2026].

Baxter International Political Spending History

As a division of Baxter International prior to the spinoff, Vantive’s operations benefited from Baxter’s established political spending infrastructure. Baxter International has historically maintained a corporate PAC and engaged in federal lobbying. Upon becoming independent, Vantive established its own lobbying operation [CREDIBLY REPORTED: OpenSecrets; Legis1 analysis, 2025].

Lobbying Activity

Vantive US Healthcare LLC reported $1.86 million in federal lobbying expenditures in 2025, its first year of independent operation [DOCUMENTED: Senate Office of Public Records lobbying disclosures, reported by Legis1, 2025].

Lobbying Firms Retained

[DOCUMENTED: Senate lobbying disclosures, compiled by Legis1]

Lobbying Issues

Vantive’s lobbying focused on [DOCUMENTED: Quarterly lobbying disclosures]:

• End-Stage Renal Disease (ESRD) reimbursement — Medicare payment rates for dialysis services
• Telehealth for remote patient monitoring — making permanent COVID-era flexibilities for home dialysis monitoring
• Breakthrough device designation — securing favorable Medicare coverage pathways for a sepsis-related technology
• H.R. 4441 — Patient Access to Innovative New Technologies Act, proposing a streamlined 4-year Medicare coverage pathway for FDA-designated breakthrough devices

Lobbying Personnel

Key lobbyists include Christopher M. Leibundguth, who previously lobbied for Baxter Healthcare, and Ellasandra Walsh Hahn, focused on Medicare and trade matters [DOCUMENTED: Lobbying disclosures, reported by Legis1].

Spending Comparison

Vantive’s $590,000 Q3 2025 lobbying spend significantly outpaced established competitors in the dialysis industry: DaVita Inc. spent $50,000 in Q3 2025 on ESRD issues, and U.S. Renal Care Inc. spent comparatively less. The Renal Healthcare Association spent $70,000 in Q2 2025 on ESRD advocacy [CREDIBLY REPORTED: Legis1 comparative analysis, 2025].

Regulatory Environment and Government Actions

Medicare ESRD Payment (CY 2025)

CMS finalized the CY 2025 ESRD Prospective Payment System rule (CMS-1805-F) on November 1, 2024, with an effective date of January 1, 2025. The rule set the ESRD PPS base rate at $273.82, a $2.80 increase from 2024 ($271.02). CMS projected total payments to all ESRD facilities would increase 2.7% compared to CY 2024 [DOCUMENTED: CMS Final Rule CMS-1805-F, November 1, 2024].

Key provisions favorable to dialysis providers:

• Home dialysis expansion for AKI patients: The rule extended Medicare payment for home-based dialysis and training for acute kidney injury beneficiaries — a new reimbursement category [DOCUMENTED: CMS Final Rule CMS-1805-F].
• Oral-only drug integration: Oral-only phosphate binders were included in the ESRD PPS with a fixed per-claim dispensing payment of $36.41 [DOCUMENTED: CMS Final Rule CMS-1805-F].
• Telehealth provisions: Remote patient monitoring flexibilities from the COVID era were extended, aligning with Vantive’s lobbying priorities [DOCUMENTED: CMS regulations; H.R. 2263 Telehealth Coverage Act of 2025].

Legislative Activity Aligned with Vantive’s Lobbying

[DOCUMENTED: Congressional records, compiled by Legis1]

Congressional Access

Representative Greg Murphy (R-NC), a physician, publicly reported meeting with Vantive to discuss remote patient monitoring [DOCUMENTED: Congressional disclosure, reported by Legis1, 2025].

Carlyle Group Ownership

Vantive is owned by funds managed by the Carlyle Group (NASDAQ: CG), one of the world’s largest private equity firms. Carlyle acquired Vantive from Baxter International for $3.8 billion [DOCUMENTED: Baxter International press release, August 12, 2024]. The Carlyle Group has its own extensive political spending and lobbying history. The private equity ownership structure means Vantive’s ballroom donation and lobbying activity serve Carlyle’s investment return objectives [DOCUMENTED: SEC filings].

Research gap: The extent of Carlyle Group’s own political spending in the Trump era, and whether Carlyle directed or encouraged Vantive’s ballroom donation, has not been publicly reported.

Conflict of Interest Analysis

Vantive’s documented spending pattern shows a company that, within months of becoming independent, invested heavily in political access:

1. January 31, 2025: Vantive becomes independent under Carlyle ownership.
2. 2025 Q1-Q3: Vantive spends $1.86 million on federal lobbying, focused on Medicare ESRD reimbursement — the single largest revenue driver for its business.
3. October 13, 2025: Vantive donates $2.5 million to the White House Ballroom project.
4. October 15, 2025: Trump hosts donor appreciation dinner at the White House.
5. Ongoing: CMS Medicare rules and congressional legislation directly affecting dialysis reimbursement are actively being shaped.

The company’s $1.86 million in lobbying substantially outpaced established, larger competitors in the dialysis industry, suggesting an aggressive strategy to influence policy during a period of active regulatory change. The $2.5 million ballroom donation — equal to more than a year’s lobbying budget — was made just two days before the Trump donor dinner.

Vantive’s disclosure of its ballroom donation in lobbying filings, while commendable for transparency, also highlights the lack of disclosure by other donors. CREW’s analysis found that at least 22 other companies that should have disclosed failed to do so [DOCUMENTED: CREW analysis, 2026].

For Trump Supporters: Questions Worth Considering

1. Vantive was a brand-new company that spent $4.36 million on lobbying and political access in its first year. For a company whose revenue depends almost entirely on Medicare, is this spending about “innovation” or about protecting reimbursement rates?

1. Vantive’s private equity owner, Carlyle Group, paid $3.8 billion for the company. The ballroom donation and lobbying spending are investments to protect that $3.8 billion bet. Should private equity firms be able to buy influence over the Medicare policies that determine their investment returns?

1. Vantive is the only ballroom donor that disclosed its contribution in lobbying filings. Why did other donors — many with larger regulatory footprints — not do the same? What does Vantive’s transparency reveal about the opacity of the rest?

1. Medicare pays $6.6 billion annually for dialysis services. Every dollar of favorable policy change to Vantive flows to Carlyle Group investors. Is this the best use of taxpayer healthcare spending?

1. The Telehealth Coverage Act and breakthrough device pathway that Vantive lobbies for may genuinely benefit patients. But should policy outcomes be influenced by companies that donated $2.5 million to the president’s personal building project?

Investigative Trails

• Carlyle Group direction of political spending: Determine whether Carlyle directed or encouraged Vantive’s ballroom donation and lobbying strategy. Examine Carlyle’s own political spending for overlapping patterns.
• Baxter International political spending transition: Track whether Baxter’s PAC and lobbying infrastructure transferred to Vantive or whether Vantive’s spending represents net new political investment.
• Medicare ESRD rule changes under Trump: Monitor CY 2026 ESRD PPS rulemaking for provisions that specifically benefit Vantive’s product lines, particularly home dialysis and breakthrough device coverage.
• H.R. 4441 beneficiaries: The Patient Access to Innovative New Technologies Act, which Vantive explicitly lobbies for, would create a streamlined Medicare coverage pathway. Identify which specific Vantive products would benefit.
• Donor dinner attendees and subsequent policy actions: FOIA requests for attendee lists and subsequent CMS communications could document the relationship between donor access and policy outcomes.
• Other Carlyle portfolio company political spending: Examine whether other Carlyle-owned healthcare companies also donated to the ballroom or MAGA Inc., which would suggest a coordinated private equity strategy.

Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@patriot.university with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.

Sources

1. Bloomberg Government, “Big Ballroom Donation Divulged by Health Care Company Vantive”, 2026. https://news.bgov.com/bloomberg-government-news/big-ballroom-donation-divulged-by-health-care-company-vantive
2. CREW, “White House ballroom donations should be disclosed on lobbying disclosure reports”, 2026. https://www.citizensforethics.org/reports-investigations/crew-investigations/white-house-ballroom-donations-should-be-disclosed-on-lobbying-disclosure-reports/
3. NBC4 Washington, “Watchdog calls for more transparency into WH ballroom donors”, 2026. https://www.nbcwashington.com/investigations/as-key-decisions-over-white-house-ballroom-loom-ethics-watchdog-calls-for-more-transparency-into-its-donors/4083622/
4. Legis1, “Kidney Care Reimbursement | Vantive Lobbies Congress”, 2025. https://legis1.com/kidney-care-reimbursement-vantive-lobbying/
5. Baxter International, “Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion”, August 12, 2024. https://www.baxter.com/baxter-newsroom/baxter-announces-definitive-agreement-divest-its-vantive-kidney-care-segment
6. Baxter International, “Baxter Reports Fourth-Quarter and Full-Year 2024 Results”, 2025. https://www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2024-results
7. SEC Filing, Baxter International 8-K re: Vantive sale completion, January 31, 2025. https://www.sec.gov/Archives/edgar/data/10456/000162828025004275/bax-2025013125xex991.htm
8. CMS, “Calendar Year 2025 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-1805-F)”, November 1, 2024. https://www.cms.gov/newsroom/fact-sheets/calendar-year-2025-end-stage-renal-disease-esrd-prospective-payment-system-pps-final-rule-cms-1805-f
9. Public Citizen, “Banquet of Greed” report, November 2025. https://www.citizen.org/wp-content/uploads/Banquet-of-Greed-Final.pdf
10. PBS News, “Who’s paying for Trump’s $300 million ballroom?”, October 24, 2025. https://www.pbs.org/newshour/politics/whos-paying-for-trumps-300-million-ballroom
11. CBS News, “What donors to Trump’s White House ballroom stand to gain from the federal government”, 2025. https://www.cbsnews.com/news/trump-ballroom-donors-white-house-stand-to-gain/
12. OpenSecrets, federal lobbying data for Baxter International and Vantive, 2024-2025. https://www.opensecrets.org

This profile documents publicly available information about political spending and government actions. It does not allege illegality. If any claim requires correction, contact patriot.university with documentation.